Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)

ADS‐5102 is a long‐acting, extended‐release capsule formulation of amantadine HCl administered once daily at bedtime. This study investigated the safety, efficacy, and tolerability of ADS‐5102 in Parkinson's disease (PD) patients with levodopa‐induced dyskinesia. This was a randomized, double‐b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pahwa, Rajesh, Tanner, Caroline M., Hauser, Robert A., Sethi, Kapil, Isaacson, Stuart, Truong, Daniel, Struck, Lynn, Ruby, April E., McClure, Natalie L., Went, Gregory T., Stempien, Mary Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024015/
https://www.ncbi.nlm.nih.gov/pubmed/25650051
http://dx.doi.org/10.1002/mds.26159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024015/
https://www.ncbi.nlm.nih.gov/pubmed/25650051
http://dx.doi.org/10.1002/mds.26159

Ejemplares similares